Home › Community-Acquired Pneumonia
Community-Acquired Pneumonia clinical trials recruiting in the U.S.
7 studies for Community-Acquired Pneumonia are recruiting participants at sites across the United States.
Cities with the most studies
By state
Recently updated studies
Azithromycin Versus Doxycycline in Hospitalized Adult Patients With Community Acquired Pneumonia Treated With Beta-lactams
RecruitingPhase 4
Ages 18 and older · All sexes · Updated Sep 24, 2026 · NCT07164131Efficacy and Safety of Trimodulin (BT588) in Subjects With Severe Community-acquired Pneumonia (sCAP)
RecruitingPhase 3
Ages 18 and older · All sexes · Updated Sep 14, 2026 · NCT05722938Fluad vs. Fluzone High-Dose Vaccine Effectiveness Among Adults ≥65 Years
RecruitingObservational studyHealthy volunteers welcome
Ages 65 and older · All sexes · Updated Aug 5, 2026 · NCT06029933AntiThrombotic Therapy to Ameliorate Clinical Complications in Community Acquired Pneumonia
RecruitingPhase 3
Ages 18 and older · All sexes · Updated Apr 21, 2026 · NCT05848713Short Versus Standard of Care Antibiotic Duration for Children Hospitalized for CAP
RecruitingPhase 4
3 Months – 18 Years · All sexes · Updated Mar 2, 2026 · NCT06494072Comparing Antibiotic Treatment Strategies for Children With Pneumonia in Outpatient Settings: (STAMPP)
Recruiting
12 Months – 71 Months · All sexes · Updated Jan 27, 2026 · NCT06986148Randomized, Embedded, Multifactorial Adaptive Platform Trial for Community- Acquired Pneumonia
RecruitingPhase 3
Ages 18 and older · All sexes · Updated Jul 12, 2024 · NCT02735707From ClinicalTrials.gov, data retrieved Sep 30, 2026. Each study sets its own eligibility; the study team decides who can join.